Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
9,906.84
7,789.46
7,738.43
8,660.38
8,383.15
8,894.84
10,917.90
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
9,906.84
7,789.46
7,738.43
8,660.38
8,383.15
8,894.84
10,917.90
Raw Material Cost
5,280.12
4,265.24
4,197.58
4,611.67
4,027.25
4,469.37
4,791.38
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
2,749.65
2,515.45
2,378.01
2,477.38
2,404.91
2,370.06
2,488.15
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.90
0.88
0.53
0.58
0.57
0.57
0.67
Selling and Distribution Expenses
3,892.53
3,562.94
3,223.05
3,326.78
3,775.32
4,538.90
5,397.21
Other Expenses
-227.29
-209.73
-186.52
-189.75
-181.15
-172.91
-76.32
Total Expenditure (Excl Depreciation)
9,651.30
8,247.26
7,933.94
8,518.91
8,396.53
9,649.78
11,914.18
Operating Profit (PBDIT) excl Other Income
255.5
-457.8
-195.5
141.5
-13.4
-754.9
-996.3
Other Income
2.75
467.45
405.04
61.59
296.42
250.64
89.81
Operating Profit (PBDIT)
628.92
372.88
554.98
566.71
753.12
-19.99
-438.28
Interest
1.90
0.88
0.53
0.58
0.57
0.57
0.67
Exceptional Items
0.00
-1.31
-50.14
9.10
2.40
-198.13
-3.90
Gross Profit (PBDT)
4,626.72
3,524.22
3,540.85
4,048.71
4,355.90
4,425.47
6,126.52
Depreciation
370.63
363.23
345.45
363.65
470.08
484.31
468.19
Profit Before Tax
256.40
7.46
158.85
211.57
284.86
-703.01
-911.04
Tax
29.18
-56.98
49.90
73.32
46.31
-101.15
745.50
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
227.22
64.44
108.96
138.26
238.54
-601.86
-1,656.54
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
227.22
64.44
108.96
138.26
238.54
-601.86
-1,656.54
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
227.22
64.44
108.96
138.26
238.54
-601.86
-1,656.54
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
12,008.58
11,610.35
12,026.07
11,906.67
11,480.80
11,385.57
11,947.09
Earnings per share (EPS)
6.55
1.86
3.14
3.98
6.87
-17.34
-47.73
Diluted Earnings per share
6.55
1.86
3.14
3.98
6.87
-17.34
-47.73
Operating Profit Margin (Excl OI)
2.58%
-5.88%
-2.53%
1.63%
-0.16%
-8.49%
-9.13%
Gross Profit Margin
6.33%
4.76%
6.52%
6.64%
9.01%
-2.46%
-4.06%
PAT Margin
2.29%
0.83%
1.41%
1.6%
2.85%
-6.77%
-15.17%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 27.18% vs 0.66% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is 252.80% vs -40.92% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 761.95% vs -163.11% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 111.11% vs 80.00% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has improved from Mar 2025
Compare Annual Results Of Wakamoto Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(JPY)
Change(%)
Net Sales
9,906.84
33,090.00
-23,183.16
-70.06%
Other Operating Income
0.00
0.00
0.00
Total Operating income
9,906.84
33,090.00
-23,183.16
-70.06%
Raw Material Cost
5,280.12
24,693.00
-19,412.88
-78.62%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
2,749.65
0.00
2,749.65
Power Cost
0
0
0.00
Manufacturing Expenses
1.90
225.00
-223.10
-99.16%
Selling and Distribution Expenses
3,892.53
6,083.00
-2,190.47
-36.01%
Other Expenses
-227.29
190.90
-418.19
-219.06%
Total Expenditure (Excl Depreciation)
9,651.30
32,910.00
-23,258.70
-70.67%
Operating Profit (PBDIT) excl Other Income
255.54
180.00
75.54
41.97%
Other Income
2.75
427.00
-424.25
-99.36%
Operating Profit (PBDIT)
628.92
2,166.00
-1,537.08
-70.96%
Interest
1.90
225.00
-223.10
-99.16%
Exceptional Items
0.00
-163.00
163.00
100.00%
Gross Profit (PBDT)
4,626.72
8,397.00
-3,770.28
-44.90%
Depreciation
370.63
1,559.00
-1,188.37
-76.23%
Profit Before Tax
256.40
221.00
35.40
16.02%
Tax
29.18
23.00
6.18
26.87%
Provisions and contingencies
0
0
0.00
Profit After Tax
227.22
198.00
29.22
14.76%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
227.22
198.00
29.22
14.76%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
227.22
198.00
29.22
14.76%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
12,008.58
19,510.00
-7,501.42
-38.45%
Earnings per share (EPS)
6.55
54.79
-48.24
-88.05%
Diluted Earnings per share
6.55
54.79
-48.24
-88.05%
Operating Profit Margin (Excl OI)
2.58%
0.54%
0.00
2.04%
Gross Profit Margin
6.33%
5.38%
0.00
0.95%
PAT Margin
2.29%
0.60%
0.00
1.69%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 990.68 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 27.18% vs 0.66% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 22.72 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 252.80% vs -40.92% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 62.62 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 761.95% vs -163.11% in Mar 2025
Annual - Interest
Interest 0.19 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 111.11% vs 80.00% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 2.58%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
